About the Company
Sierra Oncology is a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer. Sierra Oncology harnesses its deep scientific expertise to identify compounds that target the root cause of disease to advance targeted therapies with assets on the leading edge of cancer biology. Its team takes an evidence-based approach to understand the limitations of current treatments and explore new ways to change the cancer treatment paradigm. Sierra Oncology is transforming promise into patient impact.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $SRRA News
GSK bolsters cancer pipeline with $1.9bn Sierra Oncology buy
GlaxoSmithKline has agreed a deal to buy Sierra Oncology and its lead drug momelotinib for anaemia associated with the blood cancer myelofibrosis, sending the US biotech's shares skywards.
Angie You's Net Worth
This is based on reported shares across multiple companies, which include Sierra Oncology, Inc., Oric Pharmaceuticals, Inc., and RayzeBio, Inc.. Attention insiders: Dive deeper into market ...
Bakker Juliet Tammenoms's Net Worth
Who is Bakker Juliet Tammenoms? Bakker Juliet Tammenoms has an estimated net worth of $533 Million. This is based on reported shares across multiple companies, which include CORCEPT THERAPEUTICS ...
Oncology Drugs - Sierra Leone
The projected revenue for the Oncology Drugs market in Sierra Leone is expected to reach US$10.32m by 2024. It is estimated that the market will experience an annual growth rate (CAGR 2024-2028 ...
Pyxis Oncology Inc PYXS
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
AKUMIN ANNOUNCES PARTNERSHIP WITH NORTHERN NEVADA SIERRA MEDICAL CENTER FOR RADIATION ONCOLOGY SERVICES
PLANTATION, Fla., Feb. 21, 2024 /PRNewswire/ - Akumin Inc., a national provider of outpatient radiology and oncology services, and Northern Nevada Sierra Medical Center (SMC) today announced a new ...
IKNA Ikena Oncology, Inc.
Ikena Oncology, Inc. operates as an oncology company that develops differentiated therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the ...
Glaxo on the hunt for more takeover targets
The takeover of Bellus also followed the purchase last year of cancer drug maker Sierra Oncology and vaccine maker Affinivax for £1.5billion and £2.7billion respectively. ‘We are absolutely ...
Predictive Oncology Inc POAI
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Emma Walmsley
Early in 2023, British pharma giant GSK launched the world’s first RSV adult vaccine, Arexvy, for those aged 60 years and older. Walmsley, the only woman CEO of a major pharma company, told ...
What's Going On With Elevation Oncology Stock?
Elevation Oncology, Inc. (NASDAQ: ELEV) shares raced higher Monday. The company announced program updates and upcoming 2024 milestones on Friday. Here's a look at what's going on. The Details ...
Predictive Oncology Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Loading the latest forecasts...